Skip to main content

Posts

Showing posts from March, 2020

PDX Models Market | Growing at a CAGR of 16.7%

Market Growth Analysis: The global PDX models market is expected to reach to USD 167.6 Million by 2022 from USD 68.0 Million in 2016 at a CAGR of 16.7%. The growth of the overall Patient Derived Xenograft Models Market can be attributed to the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251 Objectives Of Study: 1. To define, describe, and measure the global Patient Derived Xenograft (PDX) models market by model type, tumor type, application, end user, and region 2. To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions t

Physiotherapy Equipment Market | Known and Unknown Adjacencies Impacting the Market

The  physiotherapy equipment market  is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%. The growth of this market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease. The elderly are more susceptible to various chronic and debilitating diseases. According to the World Health Organization (WHO), the incidence of strokes, dementia, and hip fractures increase exponentially with age; these are common afflictions in people over 85 years of age. Thus, the aging population, afflicted by some form of disability, will drive the market. Moreover, non-communicable diseases (such as heart diseases, cancer, and diabetes) account for about 87% of the disease burden in the aged population in low-, middle-, and high-income countries. The elderly will require three to five

Untapped Emerging Markets Driving Growth in Biosurgery Market

Changing lifestyles and eating habits have resulted in a significant increase in the prevalence of obesity and other lifestyle disorders. This is a major factor responsible for the growth in the number of surgeries performed every year across the globe. Biosurgery products play a critical role in controlling blood loss, healing wounds, and in closing the surgical sites during different types of surgeries. Owing to the proven benefits of biosurgery products and the growing awareness for the same, the overall uptake of different surgical sealants and hemostatic agents during surgical procedures is increasing. This is one of the key contributors to the growth of the  biosurgery market . In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the  biosurgery market . This is because the markets in these countries are characterized by a large patient base for target indications (such as cardiovascula

Multiplex Assays Market | Monitoring of Biosimilars in Autoimmune Diseases is Key Opportunity

The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of Companion Diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314 Opportunity: Monitoring of biosimilars in autoimmune diseases Anti-TNF-alpha biologics are proving to be an effective treatment for autoimmune diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). With the increasing healthcare costs as well as patent expirations, the number of R&D activities focusing on the development of biosimilars have increased over the last few years. The launch of biosimilars in the market is increasing t

Neuromodulation Market Trends 2020 | Driven by Parkinson’s Disease Application

The global neuromodulation market is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period. Parkinson’s disease held the largest share of the deep brain stimulation market, by application Based on application, the deep brain stimulation market is segmented into Parkinson’s disease, tremor, depression, and other DBS applications. Parkinson’s disease accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidence of the disease and growing R&D activity in this area. Download PDF Brochu

Radiotherapy Market Trends 2020 | Driven by Technological Advancement in Radiotherapy Devices

Radiotherapy Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy , and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The radiotherapy market is projected to grow from an estimated $5.6 billion in 2018 to $6.8 billion by 2023, at a CAGR of 4.1%. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567 Driver: Technological advancement Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-u

Enteral Feeding Devices: How Shift from Parenteral to Enteral Nutrition Presents an Opportunity for Revenue Growth

The enteral feeding devices market has evolved significantly owing to various technological advancements, such as programming and safety features in feeding pumps as well as user-friendly and portable feeding pumps. Factors such as rising healthcare costs; surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period. MarketsandMarkets forecasts the enteral feeding devices market to grow from USD 2.99 billion in 2019 to USD 4.14 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.7%. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035 Driver: Shift from Parenteral to Enteral Nutrition Enteral nutrition is more physiological,

Biosimulation Market Trends to 2022 "Driven by Pharmaceutical and Biotechnology companies"

The global biosimulation market is projected to reach USD 2,881 billion by 2022 from USD 1,375 billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market. Pharmaceutical and Biotechnology Companies Segment to Record the Highest CAGR: Pharmaceutical and biotechnology companies are expected to form the largest share in 2017, and is projected to register the highest CAGR during the forecast period. Increased R&D budgets of pharmaceutical and biotechnology companies and increasing adoption of inorganic growth strategies by different biosimulation service providers are likely to boost the adoption of biosimulation solutions in the pharmaceuticals and biotechnolog

Smoke Evacuation System Demand in Laparoscopic Surgery and Key Growth Driver - Market Research

The smoke evacuation system market is estimated to grow at a CAGR of 6.6% to reach $223 million by 2024 from $162 million in 2019. Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation systems market. Laparoscopic surgeries dominated the surgical smoke evacuation market in 2018 On the basis of application, the smoke evacuation systems market is segmented into medical aesthetic surgeries, laparoscopic surgeries, open general surgeries, and orthopedic surgeries. Laparoscopic surgeries accounted for the largest share of the smoke evacuation systems market in 2018. Factors such as the advantages of laparoscopic procedures over conventional open surgery and the need to im

Biosurgery Market | Latest Market Drivers and Opportunities - Market Research

The biosurgery market to grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The major factors that are expected to be driving the biosurgery market are the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302 Driver: Increasing volume of surgeries and prevalence of severe trauma injuries Changing lifestyles and eating habits have resulted in a significant increase in the prevalence of obesity and other lifestyle disorders. This is a major factor responsible for the growth in the number of surgeries performed every year across the globe. Biosurgery products play a critical role in controlling blood loss, healin

Temperature Management Market is Projected to Reach $3.0 billion by 2024

The report  " Temperature Management Market  by Product (Surface & Intravascular System - Warming & Cooling), Application (Perioperative (Preoperative Care, Operating Room), Acute Care, Newborn Care), Medical Specialties (Pediatric, Orthopedic) - Global Forecast to 2024" , is expected to grow from USD 2.6 billion in 2019 to USD 3.0 billion by 2024, at a CAGR of 3.2% during the forecast period. The increase in the incidence of chronic conditions and the subsequent increase in the number of surgical procedures are the key factors driving market growth. Patient warming systems to account for the largest share of the global temperature management market in 2019 Based on product, the patient warming systems segment is expected to account for the largest share of the temperature management market in 2019. Factors such as the rising demand for these systems in diverse hospital settings and the increasing adoption rate of invasive warming in surgical procedures such as